Data / Drug companies / Milla Pharmaceuticals Inc.
Milla Pharmaceuticals Inc.: 11 products in the FDA NDC directory, labeler code 71357
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Milla Pharmaceuticals Inc. (labeler code 71357) lists 11 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 11 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 7, 2026.
The request: Watch Milla Pharmaceuticals Inc. (FDA labeler code 71357): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71357
- Products in commercial distribution
- 11
- Packages
- 10
- Finished drugs by generic name
- 8
- Prescription products
- 11
- Over the counter products
- 0
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- August 1, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 11 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 11 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Piperacillin and tazobactam | 2 | 13 |
| Tranexamic acid | 2 | 39 |
| Sodium acetate | 2 | 5 |
| Tromethamine | 1 | 3 |
| Sodium acetate injection, usp, 200 meq/100 ml | 1 | 1 |
| Sodium acetate injection, usp, 400 meq/100 ml | 1 | 1 |
| Dihydroergotamine mesylate | 1 | 13 |
| Sodium bicarbonate | 1 | 51 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 5 | 45.5% |
| Injection, solution, concentrate | 4 | 36.4% |
| Injection, powder, lyophilized, for solution | 2 | 18.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Penicillin-class Antibacterial | 2 |
| beta Lactamase Inhibitor | 2 |
| Antifibrinolytic Agent | 2 |
| Ergotamine Derivative | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sodium Bicarbonate | 71357-004 | Injection, solution | Generic drugs (ANDA) | August 7, 2026 |
| Sodium Acetate | 71357-002 | Injection, solution, concentrate | Generic drugs (ANDA) | January 17, 2025 |
| Tromethamine | 71357-001 | Injection, solution | Generic drugs (ANDA) | December 31, 2024 |
| Sodium Acetate | 71357-009 | Injection, solution, concentrate | Generic drugs (ANDA) | December 6, 2024 |
| Sodium Acetate | 71357-008 | Injection, solution, concentrate | Generic drugs (ANDA) | October 25, 2024 |
| Sodium Acetate | 71357-007 | Injection, solution, concentrate | Generic drugs (ANDA) | October 25, 2024 |
| Piperacillin and tazobactam | 71357-022 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 11, 2023 |
| Tranexamic Acid | 71357-018 | Injection, solution | Generic drugs (ANDA) | September 30, 2021 |
| Tranexamic Acid | 71357-017 | Injection, solution | Generic drugs (ANDA) | September 30, 2021 |
| Dihydroergotamine Mesylate | 71357-013 | Injection, solution | Generic drugs (ANDA) | September 30, 2021 |
| Piperacillin and tazobactam | 71357-023 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 1, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.